Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Sovaldi And Drug Pricing: The United States Of Saps (GILD)
Seeking Alpha
Thu, 06/19/14 - 08:54 am
Sovaldi
drug pricing
hepatitis C
Gilead Sciences
Expecting hostile suitors, Shire brings in reinforcements
Fierce Pharma
Wed, 06/18/14 - 05:31 am
Shire
M&A
Bristol-Myers Squibb
Amgen
AbbVie
Gilead Sciences
Biogen Idec
Is This Gilead's Worst Nightmare?
Motley Fool
Tue, 06/17/14 - 07:00 pm
Gilead Sciences
Sovaldi
hepatitis C
Enanta Pharmaceuticals
AbbVie
Britain's cost agency not ready to back Gilead hepatitis C drug
Yahoo/Reuters
Mon, 06/16/14 - 08:47 pm
UK
Gilead Sciences
Sovaldi
hepatitis C
InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For
Seeking Alpha
Sun, 06/15/14 - 06:31 pm
InterMune
Esbriet
Actelion
Gilead Sciences
What Is Next For The Hepatitis C Space?
Seeking Alpha
Fri, 06/13/14 - 11:05 am
hepatitis C
Conatus Pharmaceuticals
Gilead Sciences
Merck
Idenix
Merck's Acquisition Of Idenix Pharmaceuticals Is An Admission Of Inferiority To Sovaldi Regimens
Seeking Alpha
Tue, 06/10/14 - 07:19 pm
Idenix
Merck
M&A
hepatitis C
Sovaldi
Gilead Sciences
Gilead Sciences: Killing The Competition With Sovaldi; But Does This Make Gilead A One-Trick Pony?
Seeking Alpha
Mon, 06/9/14 - 07:53 pm
Sovaldi
Gilead Sciences
hepatitis C
Gilead Down On Merck-Idenix Deal, But Little To Fear
Seeking Alpha
Mon, 06/9/14 - 02:50 pm
Gilead Sciences
Merck
Idenix
hepatitis C
M&A
HCV players moving after Merck buys Idenix
The Fly on the Wall
Mon, 06/9/14 - 12:01 pm
Merck
Gilead Sciences
Idenix
M&A
Achillion
JNJ
AbbVie
Merck “More Formidable” Competitor for Gilead, But Still Years Away
Barron's
Mon, 06/9/14 - 11:58 am
Merck
Gilead Sciences
Idenix
M&A
hepatitis C
How Gilead Sciences Can Deliver A Double
Forbes
Fri, 06/6/14 - 10:05 am
Gilead Sciences
Sovaldi
What Price Innovation? The Sovaldi Saga
Forbes
Thu, 05/29/14 - 09:43 am
innovation
Sovaldi
Gilead Sciences
drug pricing
hepatitis C
Insurers scrutinize drug costs after $84,000 Sovaldi surprise
Yahoo/Reuters
Wed, 05/28/14 - 02:01 pm
drug pricing
insurance
Sovaldi
Gilead Sciences
The 3 Biggest Biotech Wins of the Week
Motley Fool
Wed, 05/28/14 - 10:52 am
GS-5806
Gilead Sciences
Factor XI inhibitor
Isis Pharmaceuticals
InterMune
pirfenidone
IPF
Recent Developments In Gilead's Non-Hepatitis C Programs
Seeking Alpha
Tue, 05/27/14 - 11:55 am
Gilead Sciences
RSV
GS-5806
Viread
TAF
Ranexa
atrial fibrillation
3 Breakthrough Drugs Yield 1 Instant Blockbuster
Motley Fool
Sun, 05/25/14 - 10:26 am
Roche
Gazyva
Imbruvica
JNJ
Gilead Sciences
Sovaldi
mantle cell lymphoma
chronic lymphocytic leukemia
leukemia
Biogen
hepatitis
hepatitus C
Side effect analysis suggests Gilead's hep C wonder Sovaldi is safer than rivals, too
Fierce Pharma
Tue, 05/20/14 - 11:47 am
Sovaldi
side effects
hepatitis C
Gilead Sciences
CDC backing for preventive Truvada could multiply Gilead's scripts 50-fold
Fierce Pharma
Thu, 05/15/14 - 11:11 am
CDC
Truvada
HIV
Gilead Sciences
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
Thu, 05/15/14 - 08:29 am
ASCO
Gilead Sciences
AbbVie
Pharmacyclics
Imbruvica
CLL
Idelalisib
mantle cell lymphoma
ABT-199
Pages
« first
‹ previous
…
73
74
75
76
77
78
79
80
81
…
next ›
last »